Named on one round in the feed.
Since 2022-06-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Elucid A medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $27M | 2022-06-22 | [ PART ] |